ABLP treatment demonstrates potential in improving cardiac dysfunction and depressive behaviors in a mouse model of myocardial infarction via inflammatory pathway regulation.
ABLP treatment exerts beneficial effects in improving cardiac dysfunction and alleviating depressive behaviors in MI mice by inhibiting the M1/TNF-α/TNFR1/NF-κB signaling pathway. The underlying inflammatory response may be associated with cortical 5-HT levels.
Zhang et al. (Fri,) studied this question.